Qiming Wang

No ORCID on file · 13 papers in corpus · active 2010-2026

Study types

  • article 8
  • dataset 2
  • other 2
  • erratum 1

Condition tags

  • endometriosis 9
  • adenomyosis 4
  • infertility 3
  • mesh:D004715 2
  • dysmenorrhea 1
  • mesh:D004412 1
dataset 2026
·doi:10.6084/m9.figshare.32576619.v1

Integrative WES–RNA‑seq profiling highlights a coordinated invasion‑like program in endometriosis with functional dependence on PI3K/AKT signaling, supporting PI3K/AKT as a mechanistically grounded target for anti‑invasive strategies in end…

dataset 2026
·doi:10.6084/m9.figshare.32576619

Integrative WES–RNA‑seq profiling highlights a coordinated invasion‑like program in endometriosis with functional dependence on PI3K/AKT signaling, supporting PI3K/AKT as a mechanistically grounded target for anti‑invasive strategies in end…

article 2025
Pakistan journal of pharmaceutical sciences

To elucidate the mechanisms of endometriosis-associated infertility and identify potential drug targets by targeting PI3K/Akt and NF-κB signaling pathways. This study assessed clinical characteristics, inflammatory and oxidative stress biom…

other 2024
BMC women's health ·doi:10.1186/s12905-024-02985-5

INTRODUCTION: Endometriosis (EM) is a multifactorial disease that affects 10 - 15% of women of reproductive age. Additionally, 30-50% of women with EM suffer from infertility. The mechanism of infertility caused by EM has not yet been consi…

erratum 2024
BMC women's health ·doi:10.1186/s12905-024-03194-w
article 2024
New biotechnology ·doi:10.1016/j.nbt.2024.11.001

Uterine adenomyosis causing attention to the abnormal smooth muscle layer has recently received increasing attention, which has created the need for a method that can efficiently collect high purity uterine smooth muscle cells (USMC) in a l…

article 2023
JAMA network open ·doi:10.1001/jamanetworkopen.2023.17860

Importance: Adenomyosis is a common chronic gynecological disorder, and its treatment is an unmet need. New therapies need to be developed. Mifepristone is being tested for adenomyosis treatment. Objective: To determine whether mifepristone…

other 2022
Frontiers in immunology ·doi:10.3389/fimmu.2022.945504

BACKGROUND: Adenomyosis is an estrogen-dependent gynecological disease. The pathogenesis of chronic pain, the main clinical symptom of adenomyosis, remains undefined. As a combination lymphocyte with both T-cell and natural killer (NK)-cell…

article 2021
·doi:10.2139/ssrn.3897694
article 2013
International journal of fertility & sterility

BACKGROUND: The present study aims to explore the significance of the expression of growth hormone-releasing hormone (GHRH) and its receptor splice variant 1 (GHRHSV1) in endometriosis (EM). MATERIALS AND METHODS: In this research paper 80 …

article 2013

Background: The present study aims to explore the significance of the expression ofgrowth hormone-releasing hormone (GHRH) and its receptor splice variant 1 (GHRHSV1)in endometriosis (EM).Materials and Methods: In this research paper 80 EM …

article 2013

Background: The present study aims to explore the significance of the expression of growth hormone-releasing hormone (GHRH) and its receptor splice variant 1 (GHRHSV1) in endometriosis (EM). Materials and Methods: In this research paper 80 …

article 2010

Objective To explore the laparoscopy combined with medical treatment of endometriosis with infertility clinical value.Methods from 2005 to 2009 our hospital endometriosis 341 cases of infertility were randomly divided into three groups and …